The CellSearch system enables CTCs to be analyzed for expression of PD‐L1 as a liquid biopsy, and this may counter tumor heterogeneity and also provide tumor sampling without the need of a new tissue biopsy. This evidence concerns the gene CD274 and neoplasm.